Log in

NYSE:GFL - Passage Bio Stock Price, Forecast & News

$14.96
-0.20 (-1.32 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$14.40
Now: $14.96
$15.14
50-Day Range N/A
52-Week Range
$13.80
Now: $14.96
$17.95
Volume552,593 shs
Average Volume3.35 million shs
Market Capitalization$4.88 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
GFL Environmental Inc. operates as a diversified environmental services company in North America. The company offers non-hazardous solid waste management, infrastructure and soil remediation, and liquid waste management services. Its solid waste management business line includes the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste for municipal, residential, and commercial and industrial customers. The company's infrastructure and soil remediation business line provides remediation of contaminated soils, as well as complementary services, including civil, demolition, and excavation and shoring services. Its liquid waste management business collects, transports, processes, recycles, and/or disposes a range of liquid wastes from commercial and industrial customers. The company was founded in 2007 and is headquartered in Vaughan, Canada.
Read More

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorBusiness Services
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees11,500
Market Cap$4.88 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive GFL News and Ratings via Email

Sign-up to receive the latest news and ratings for GFL and its competitors with MarketBeat's FREE daily newsletter.


Passage Bio (NYSE:GFL) Frequently Asked Questions

How has Passage Bio's stock been impacted by COVID-19 (Coronavirus)?

Passage Bio's stock was trading at $16.52 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GFL stock has decreased by 9.4% and is now trading at $14.96. View which stocks have been mosted impacted by Coronavirus.

Has Passage Bio been receiving favorable news coverage?

Media stories about GFL stock have been trending somewhat positive this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Passage Bio earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the immediate future. View the latest news aboutPassage Bio.

Who are some of Passage Bio's key competitors?

Who are Passage Bio's key executives?

Passage Bio's management team includes the following people:
  • Mr. Patrick Dovigi, Founder, Chairman, Pres & CEO (Age 40)
  • Mr. Luke Pelosi, Exec. VP & CFO (Age 39)
  • Ms. Mindy B. Gilbert, Exec. VP & Gen. Counsel (Age 47)
  • Mr. Craig Orenstein, Vice-Pres of Corp. Devel.
  • Mr. Richard R. Early, Vice-Pres of HR

When did Passage Bio IPO?

(GFL) raised $1.4 billion in an initial public offering (IPO) on Tuesday, March 3rd 2020. The company issued 75,000,000 shares at a price of $19.00 per share. JPMorgan, BMO Capital Markets, Goldman Sachs, RBC Capital Markets and Scotiabank served as the underwriters for the IPO and Barclays, BC Partners, Raymond James, Stife, TD Securities, BofA Securities, CIBC Capital Markets, HSBC and National Bank Financial were co-managers.

What is Passage Bio's stock symbol?

Passage Bio trades on the New York Stock Exchange (NYSE) under the ticker symbol "GFL."

When does the company's quiet period expire?

Passage Bio's quiet period expires on Monday, April 13th. Passage Bio had issued 75,000,000 shares in its public offering on March 3rd. The total size of the offering was $1,425,000,000 based on an initial share price of $19.00. During the company's quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Passage Bio?

Shares of GFL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Passage Bio's stock price today?

One share of GFL stock can currently be purchased for approximately $14.96.

How big of a company is Passage Bio?

Passage Bio has a market capitalization of $4.88 billion. Passage Bio employs 11,500 workers across the globe. View additional information about Passage Bio.


MarketBeat Community Rating for Passage Bio (NYSE GFL)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about Passage Bio and other stocks. Vote "Outperform" if you believe GFL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GFL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel